---
document_datetime: 2026-01-19 17:15:16
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/xenpozyme-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: xenpozyme-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.4081055
conversion_datetime: 2026-01-20 20:32:54.912465
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.69.0
  docling-core: 2.60.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Xenpozyme

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number         | Scope   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------------|---------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| PSUR / EMA/PSUR/0000282268 | - -     | 13/11/2025                          | 08/01/2026                                  |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| Variation type IB / EMA/VR/0000293598   | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted   | 16/09/2025   | N/A   |
|-----------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|